N-acetylcysteine ameliorates acute kidney injury but not glomerular hemorrhage in an animal model of warfarin-related nephropathy
Authors:
Open Access
- 15 June 2013
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 304 (12) , F1421-F1427
Abstract
Warfarin-related nephropathy (WRN) occurs under conditions of overanticoagulation with warfarin. WRN is characterized by glomerular hemorrhage with occlusive tubular red blood cell (RBC) casts and acute kidney injury (AKI). Herein we test the hypothesis that oxidative stress plays a role in the AKI of WRN. 5/6 Nephrectomy rats were treated with either warfarin (0.04 mg·kg−1·day−1) alone or with four different doses of the antioxidant N-acetylcysteine (NAC). Also tested was the ability of our NAC regimen to mitigate AKI in a standard ischemia-reperfusion model in the rat. Warfarin resulted in a threefold or greater increase in prothrombin time in each experimental group. Serum creatinine (Scr) increased progressively in animals receiving only warfarin + vehicle. However, in animals receiving warfarin + NAC, the increase in Scr was lessened, starting at 40 mg·kg−1·day−1NAC, and completely prevented at 80 mg·kg−1·day−1NAC. NAC did not decrease hematuria or obstructive RBC casts, but mitigated acute tubular injury. Oxidative stress in the kidney was increased in animals with WRN and it was decreased by NAC. The NAC regimen used in the WRN model preserved kidney function in the ischemia-reperfusion model. Treatment with deferoxamine (iron chelator) did not affect WRN. No iron was detected in tubular epithelial cells. In conclusion, this work taken together with our previous works in WRN shows that glomerular hematuria is a necessary but not sufficient explanation for the AKI in WRN. The dominant mechanism of the AKI of WRN is tubular obstruction by RBC casts with increased oxidative stress in the kidney.Keywords
This publication has 42 references indexed in Scilit:
- Relationship between antioxidant enzyme genotype and activity and kidney function: a case-control studyClinical Nephrology, 2012
- 5/6 Nephrectomy as a Validated Rat Model Mimicking Human Warfarin-Related NephropathyAmerican Journal of Nephrology, 2012
- N-acetylcysteine prevents pulmonary edema and acute kidney injury in rats with sepsis submitted to mechanical ventilationAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2012
- Warfarin-Related Nephropathy Modeled by Nephron Reduction and Excessive AnticoagulationJournal of the American Society of Nephrology, 2011
- Podocytopathy in Diabetes: A Metabolic and Endocrine DisorderAmerican Journal of Kidney Diseases, 2011
- Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rateKidney International, 2011
- Multiple-Dose Pharmacokinetics and Pharmacodynamics of N-Acetylcysteine in Patients with End-Stage Renal DiseaseClinical Journal of the American Society of Nephrology, 2010
- N-Acetylcysteine for the Management of Anemia and Oxidative Stress in Hemodialysis PatientsNephron Clinical Practice, 2010
- N-acetylcysteine protects against renal injury following bilateral ureteral obstructionNephrology Dialysis Transplantation, 2008
- The role of N-acetylcysteine in preventing radiographic contrast-induced nephropathyClinical Nephrology, 2004